This course consists of 1 module. You’ll earn 4 CE credits upon completion.
Most odontogenic infections are polymicrobial. The number of isolated strains ranges from 1 to 10 with an average number of approximately 4 isolates per infection. The majority of these infections can be resolved satisfactorily through primary dental care. When antibacterial chemotherapy is indicated, the drug of choice should be either the most effective drug against infective pathogens or the least toxic alternative among several available agents.
Dr. Geza Terezhalmy will discuss the pharmacology of antibacterial agents and present evidence-based information that will help you with the selection of the most appropriate choice for the management of an odontogenic infection.
Upon completion, practitioners will be able to understand the etiology of odontogenic infections and the factors to consider in the selection of antibacterial agents.
In addition, key topics to be discussed include:
- Microbiology of odontogenic infections
- Therapeutic considerations for each line of treatment
- Antibacterial prophylaxis
- Potential adverse drug events associated with antibacterial agents
All sales are final.
Purchase of this course grants access for one year and requires an internet connection, computer with video and audio capabilities, and in some cases, Adobe Reader to view handouts and articles.
Watch the video and complete the quiz to earn 4 CE credits.
Scientific support and additional resources are available here.
NOTE: Many dental boards require that a specified portion of your CE credits be via in-person attendance at live courses. Check your state's rules!
010 Basic Sciences (Pharmacotherapeutics) – 4.00 hour
Dr. Geza T. Terezhalmy received his DDS degree from Case Western Reserve School of Dental Medicine and his MA from The George Washington University. Currently, he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. He has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice, and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and the American Academy of Oral Medicine.
DOCS online courses are available to the purchaser for one year from date of purchase.
No refund of course tuition is available.